Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 40 citing articles:

Novel Tumor-Targeting Nanoparticles for Cancer Treatment—A Review
Adelina-Gabriela Niculescu, Alexandru Mihai Grumezescu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5253-5253
Open Access | Times Cited: 69
Cubosomes as an emerging platform for drug delivery: a review of the state of the art
Mohammed A. S. Abourehab, Mohammad Javed Ansari, Anshul Singh, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 15, pp. 2781-2819
Closed Access | Times Cited: 68
Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis
Tohada M. AL‐Noshokaty, Noha M. Mesbah, Dina M. Abo‐Elmatty, et al.
Life Sciences (2022) Vol. 303, pp. 120675-120675
Closed Access | Times Cited: 53
Cubosomes: Design, Development, and Tumor-Targeted Drug Delivery Applications
Hassaan Umar, Habibah A. Wahab, Amirah Mohd Gazzali, et al.
Polymers (2022) Vol. 14, Iss. 15, pp. 3118-3118
Open Access | Times Cited: 42
The cubosome-based nanoplatforms in cancer therapy: Seeking new paradigms for cancer theranostics
B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, Saad Ali Alshehri, et al.
Environmental Research (2023) Vol. 237, pp. 116894-116894
Closed Access | Times Cited: 26
Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling
Sameh Saber, Eslam E. Abd El-Fattah, A. M. Abdelhamid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114196-114196
Open Access | Times Cited: 23
Liposomes to Cubosomes: The Evolution of Lipidic Nanocarriers and Their Cutting-Edge Biomedical Applications
Nishtha Attri, Swarnali Das, Jhimli Banerjee, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 5, pp. 2677-2694
Open Access | Times Cited: 8
Ambroxol, a mucolytic agent, boosts HO‐1, suppresses NF‐κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis
Simona Cavalu, Hossam Sharaf, Sameh Saber, et al.
The FASEB Journal (2022) Vol. 36, Iss. 9
Open Access | Times Cited: 32
Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Updated Review
Yosif Almoshari
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 600-600
Open Access | Times Cited: 30
Ganetespib (STA-9090) augments sorafenib efficacy via necroptosis induction in hepatocellular carcinoma: Implications from preclinical data for a novel therapeutic approach
Sameh Saber, Alexandru Madalin Hasan, Osama A. Mohammed, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114918-114918
Open Access | Times Cited: 18
Anticancer effect of propranolol on diethylnitrosamine‐induced hepatocellular carcinoma rat model
Yomna M. Tamim, Ahmed Nagy, Ahmed M. Abdellah, et al.
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 4, pp. 742-757
Closed Access | Times Cited: 6
Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application
A. M. Abdelhamid, Sameh Saber, Mahmoud E. Youssef, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112455-112455
Open Access | Times Cited: 40
Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachloride
A. M. Abdelhamid, Mahmoud E. Youssef, Eslam E. Abd El-Fattah, et al.
Life Sciences (2021) Vol. 286, pp. 120070-120070
Open Access | Times Cited: 33
Carbocisteine as a Modulator of Nrf2/HO-1 and NFκB Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative Colitis
A. M. Abdelhamid, Mahmoud E. Youssef, Simona Cavalu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Mirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model
Rasha Abdelhady, Simona Cavalu, Sameh Saber, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114553-114553
Open Access | Times Cited: 13
Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
Zhao-Shan Niu, Wenhong Wang, Xiao-Jun Niu
World Journal of Gastroenterology (2022) Vol. 28, Iss. 46, pp. 6433-6477
Open Access | Times Cited: 20
Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems
Jassica S. L. Leu, Jasy J. X. Teoh, Angel L. Q. Ling, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1421-1421
Open Access | Times Cited: 12
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations
Osama A. Mohammed, Mustafa Ahmed Abdel‐Reheim, Mohannad Mohammad S. Alamri, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1080-1080
Open Access | Times Cited: 12
Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-κB signaling: A new challenge for unmet therapeutic needs
Sameh Saber, Mohamed Nasr, Mohamed M.Y. Kaddah, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112731-112731
Open Access | Times Cited: 18
Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosis
Dalia H. El‐Kashef, Mahmoud E. Youssef, Mohamed Hussein Arbab Nasr, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113487-113487
Open Access | Times Cited: 16
Linagliptin, a DPP‐4 inhibitor, activates AMPK/FOXO3a and suppresses NFκB to mitigate the debilitating effects of diethylnitrosamine exposure in rat liver: Novel mechanistic insights
Rasha Abdelhady, Osama A. Mohammed, Ahmed S. Doghish, et al.
The FASEB Journal (2024) Vol. 38, Iss. 4
Closed Access | Times Cited: 3
Diacetylrhein, an anthraquinone antiarthritic agent, suppresses dextran sodium sulfate-induced inflammation in rats: A possible mechanism for a protective effect against ulcerative colitis
Mona H. Zohny, Mohammed Alrouji, Sharif Alhajlah, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113651-113651
Open Access | Times Cited: 15
Box Behnken optimization of cubosomes for enhancing the anticancer activity of metformin: Design, characterization, and in-vitro cell proliferation assay on MDA-MB-231 breast and LOVO colon cancer cell lines
Randa Mohammed Zaki, Layla A. Al‐Kharashi, Omnia M. Sarhan, et al.
International Journal of Pharmaceutics X (2023) Vol. 6, pp. 100208-100208
Open Access | Times Cited: 8
Fabrication and Assessment of Orodispersible Tablets Loaded with Cubosomes for the Improved Anticancer Activity of Simvastatin against the MDA-MB-231 Breast Cancer Cell Line
Randa Mohammed Zaki, Amal El Sayeh Abou El Ela, Alanood S. Almurshedi, et al.
Polymers (2023) Vol. 15, Iss. 7, pp. 1774-1774
Open Access | Times Cited: 7
Vesicular approach of cubosomes, its components, preparation techniques, evaluation and their appraisal for targeting cancer cells
Sehrish Iqbal, Muhammad Zaman, Muhammad Ahsan Waqar, et al.
Journal of Liposome Research (2023) Vol. 34, Iss. 2, pp. 368-384
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top